The company specializes in molecular diagnostic and medical device manufacturing. MTek is positioning itself as the Philippines' premier health biotechnology company. It focuses on developing and manufacturing portable diagnostic kits for infectious diseases. Its technology pipeline includes novel point-of-care solutions serving domestic and regional markets. This technology improves the ability to perform key medical tasks such as precise administration of medicine, pharmaceutical development, and advanced diagnostics for early detection of diseases like cancer and genetic disorders. 

Investments like these not only strengthen medical research in the country. They promise preventive health and better treatment to those who need it. NDC's investment of Php 70 million supports MTek's modernization efforts, enabling the company to expand its R&D capabilities and enhance its manufacturing facilities to meet global standards.